FDA grants regular approval to pembrolizumab and lenvatinib for advanced endometrial carcinoma July 27, 2021 Auto Bot News 0 FDA grants regular approval to pembrolizumab and lenvatinib for advanced endometrial carcinoma – Oncology – Cancer